Literature DB >> 22069033

Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

Michele Gaeta1, Sonia Messina, Achille Mileto, Gian Luca Vita, Giorgio Ascenti, Sergio Vinci, Antonio Bottari, Giuseppe Vita, Nicola Settineri, Daniele Bruschetta, Sergio Racchiusa, Fabio Minutoli.   

Abstract

PURPOSE: To examine the usefulness of dual-echo dual-flip angle spoiled gradient recalled (SPGR) magnetic resonance imaging (MRI) technique in quantifying muscle fat fraction (MFF) of pelvic and thighs muscles as a marker of disease severity in boys with Duchenne muscular dystrophy (DMD), by correlating MFF calculation with clinical assessments. We also tried to identify characteristic patterns of disease distribution.
MATERIALS AND METHODS: Twenty consecutive boys (mean age, 8.6 years ± 2.3 [standard deviation, SD]; age range, 5-15 years; median age, 9 years;) with DMD were evaluated using a dual-echo dual-flip angle SPGR MRI technique, calculating muscle fat fraction (MFF) of eight muscles in the pelvic girdle and thigh (gluteus maximus, adductor magnus, rectus femoris, vastus lateralis, vastus medialis, biceps femoris, semitendinosus, and gracilis). Color-coded parametric maps of MFF were also obtained. A neurologist who was blinded to the MRI findings performed the clinical assessments (patient age, Medical Research Council score, timed Gower score, time to run 10 m). The relationships between mean MFF and clinical assessments were investigated using Spearman's rho coefficient. Positive and negative correlations were evaluated and considered significant if the P value was < 0.05.
RESULTS: The highest mean MFF was found in the gluteus maximus (mean, 46.3 % ± 24.5 SD), whereas the lowest was found in the gracilis muscle (mean, 2.7 % ± 4.7 SD). Mean MFF of the gluteus maximus was significantly higher than that of the other muscles (P < 0.01), except for the adductor magnus and biceps muscles. A significant positive correlation was found between the mean MFF of all muscles and the patients age (20 patients; P < 0.005), Medical Research Council score (19 patients; P < 0.001), timed Gower score (17 patients; P < 0.03), and time to run 10 m (20 patients; P < 0.001). A positive correlation was also found between the mean MFF of the gluteus maximus muscle and the timed Gower score. Color-coded maps provided an efficient visual assessment of muscle fat content and its heterogeneous distribution.
CONCLUSION: Muscle fat fraction calculation and mapping using the dual-echo dual-flip angle SPGR MRI technique are useful markers of disease severity and permit patterns of disease distribution to be identified in patients with DMD.

Entities:  

Mesh:

Year:  2011        PMID: 22069033     DOI: 10.1007/s00256-011-1301-5

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  26 in total

1.  T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.

Authors:  Hee Kyung Kim; Tal Laor; Paul S Horn; Judy M Racadio; Brenda Wong; Bernard J Dardzinski
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

2.  MRI for the demonstration of subclinical muscle involvement in muscular dystrophy.

Authors:  S Sookhoo; I Mackinnon; K Bushby; P F Chinnery; D Birchall
Journal:  Clin Radiol       Date:  2007-02       Impact factor: 2.350

3.  Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis.

Authors:  J Phoenix; D Betal; N Roberts; T R Helliwell; R H Edwards
Journal:  Muscle Nerve       Date:  1996-03       Impact factor: 3.217

4.  Clinical trial in Duchenne dystrophy. I. The design of the protocol.

Authors:  M H Brooke; R C Griggs; J R Mendell; G M Fenichel; J B Shumate; R J Pellegrino
Journal:  Muscle Nerve       Date:  1981 May-Jun       Impact factor: 3.217

5.  Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.

Authors:  Jill E Mayhew; Julaine M Florence; Thomas P Mayhew; Erik K Henricson; Robert T Leshner; Robert J McCarter; Diana M Escolar
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

6.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging.

Authors:  Franklin A Marden; Anne M Connolly; Marilyn J Siegel; David A Rubin
Journal:  Skeletal Radiol       Date:  2004-10-22       Impact factor: 2.199

7.  North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.

Authors:  Elena Mazzone; Diego Martinelli; Angela Berardinelli; Sonia Messina; Adele D'Amico; Gessica Vasco; Marion Main; Luca Doglio; Luisa Politano; Filippo Cavallaro; Silvia Frosini; Luca Bello; Adelina Carlesi; Anna Maria Bonetti; Elisabetta Zucchini; Roberto De Sanctis; Marianna Scutifero; Flaviana Bianco; Francesca Rossi; Maria Chiara Motta; Annalisa Sacco; Maria Alice Donati; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Marika Pane; Elisabetta Pasquini; Claudio Bruno; Giuseppe Vita; Chiara de Waure; Enrico Bertini; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2010-07-14       Impact factor: 4.296

8.  Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France.

Authors:  E Mercuri; A Mayhew; F Muntoni; S Messina; V Straub; G J Van Ommen; T Voit; E Bertini; K Bushby
Journal:  Neuromuscul Disord       Date:  2008-09-24       Impact factor: 4.296

9.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182

Review 10.  Genetic treatments in muscular dystrophies.

Authors:  Francesco Muntoni; Dominic Wells
Journal:  Curr Opin Neurol       Date:  2007-10       Impact factor: 5.710

View more
  51 in total

1.  Volume and fat infiltration of spino-pelvic musculature in adults with spinal deformity.

Authors:  Bertrand Moal; Nicolas Bronsard; José G Raya; Jean Marc Vital; Frank Schwab; Wafa Skalli; Virginie Lafage
Journal:  World J Orthop       Date:  2015-10-18

Review 2.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

3.  [Contrast in static images in clinical magnetic resonance imaging. Part 2: Sequences for various contrast weightings and applications].

Authors:  F Schick
Journal:  Radiologe       Date:  2013-08       Impact factor: 0.635

Review 4.  Quantitative proton MR techniques for measuring fat.

Authors:  H H Hu; H E Kan
Journal:  NMR Biomed       Date:  2013-10-03       Impact factor: 4.044

Review 5.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

6.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Sean C Forbes; Sunita Mathur; Sean A Germain; Claudia R Senesac; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-04-13       Impact factor: 4.296

Review 7.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

8.  Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Hyun Su Kim; Jae-Hun Kim; Byung-Ok Choi
Journal:  Eur Radiol       Date:  2020-10-30       Impact factor: 5.315

9.  Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.

Authors:  Harmen Reyngoudt; Benjamin Marty; Jean-Marc Boisserie; Julien Le Louër; Cedi Koumako; Pierre-Yves Baudin; Brenda Wong; Tanya Stojkovic; Anthony Béhin; Teresa Gidaro; Yves Allenbach; Olivier Benveniste; Laurent Servais; Pierre G Carlier
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

10.  Objective measurement of minimal fat in normal skeletal muscles of healthy children using T2 relaxation time mapping (T2 maps) and MR spectroscopy.

Authors:  Hee Kyung Kim; Suraj Serai; Arnold C Merrow; Lily Wang; Paul S Horn; Tal Laor
Journal:  Pediatr Radiol       Date:  2013-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.